AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 33085033
Drug: JNJ‐55920839 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐55920839 10 mg/kg IV 6 times biweekly in subjects with SLE
Trial: 33085033
Drug: JNJ‐55920839 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐55920839 (various doses between 0.3 and 15 mg/kg IV or 1 mg/kg SC) in healthy subjects
Trial: 33085033
Drug: JNJ‐55920839 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐55920839 (10 mg/kg IV) in subjects with SLE
Trial: 33085033
Drug: JNJ‐55920839 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐55920839 (various doses) in healthy subjects
Trial: 34849546
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (2000 IU/d) with baseline 25(OH)D <20 ng/mL
Trial: 34849546
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (2000 IU/d) with baseline 25(OH)D of 20-30 ng/mL
Trial: 36283748
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care treatment
Trial: 34334720
Drug: CHO hydrogel
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO hydrogel (90 g·h‐1 of 2:1 glucose‐fructose)
Trial: 34334720
Drug: Standard CHO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard CHO solution (nonhydrogel)
Trial: 34139464
Drug: modified lower-protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified lower-protein (mLP) infant formula (1.7 g protein/100 kcal)
Trial: 34139464
Drug: control formula
RxNorm normalized name: Anti Acne Control Formula Top
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control formula (CTRL) (2.1 g protein/100 kcal)
Trial: 35481442
Drug: Gabapentin 20
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 20 mg/kg
Trial: 35733283
Drug: Intravenous acetazolamide
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous acetazolamide (500 mg)
Trial: 32424868
Drug: Split high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split high-dose sennoside solutions (1000 mg)
Trial: 32424868
Drug: Split-dose polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-dose polyethylene glycol (4 L)
Trial: 35102477
Drug: Mini-implant assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini-implant assisted rapid palatal expansion (MARPE)
Trial: 36883362
Drug: Reference drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference drug
Trial: 35986649
Drug: Oral nutrition
RxNorm normalized name: BAGS/TUBES/SUPPLIES FOR ORAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutrition supplements (ONSs) (400 kcal/day) and family-centered nutrition education (once every 2 weeks)
Trial: 35986649
Drug: Oral nutrition
RxNorm normalized name: BAGS/TUBES/SUPPLIES FOR ORAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutrition supplements (ONSs) and family-centered nutrition education
Trial: 34472598
Drug: Slow breathing
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow breathing exercise (SBE) performed at home, 30 minutes daily for 12 weeks
Trial: 39260927
Drug: Evogliptin 5
RxNorm normalized name: alogliptin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evogliptin 5 mg
Trial: 33956209
Drug: Loop diuretic
RxNorm normalized name: Loop diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loop diuretic usage > 40 mg furosemide-equivalent dose
Trial: 33956209
Drug: Loop diuretic
RxNorm normalized name: Loop diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loop diuretic usage 1-40 mg furosemide-equivalent dose
Trial: 33956209
Drug: No baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No baseline loop diuretic usage
Trial: 35451469
Drug: Magnesium (3.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (3.2 g daily for 72 hours preoperatively and 1.6 g on the day of surgery)
Trial: 34081085
Drug: Risk-reducing salpingo-oophorectomy
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risk-reducing salpingo-oophorectomy (RRSO) without hormone replacement therapy
Trial: 34081085
Drug: Risk-reducing salpingo-oophorectomy
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risk-reducing salpingo-oophorectomy (RRSO) with hormone replacement therapy
Trial: 32522273
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose Lingguizhugan decoction (SLGD)
Trial: 32522273
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose Lingguizhugan decoction (LLGD)
Trial: 34693689
Drug: Recognan (citicoline),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recognan (citicoline), 500 mg daily for 30 days
Trial: 32784231
Drug: Low-dose lidocaine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose lidocaine (CIESI-L)
Trial: 32903044
Drug: Pharmacological therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological therapy
Trial: 35223106
Drug: High-dose tranexamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose tranexamic acid (TXA)
Trial: 33978745
Drug: Zoledronate infusion
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronate infusion after denosumab treatment (≤ 6 Group)
Trial: 33978745
Drug: Zoledronate infusion
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronate infusion after denosumab treatment (> 6 Group)
Trial: 33978745
Drug: Correlation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correlation of denosumab treatment duration with LS-BMD change
Trial: 33891348
Drug: Fremanezumab quarterly
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fremanezumab quarterly (675 mg)
Trial: 32958075
Drug: Fremanezumab monthly
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fremanezumab monthly (675 mg)
Trial: 33477404
Drug: Tocotrienol-rich vitamin
RxNorm normalized name: tocotrienols / vitamin E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocotrienol-rich vitamin E (Tocovid SupraBioTM; Hovid Berhad, Ipoh, Malaysia) 400 mg daily
Trial: 34120417
Drug: 1% prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% prednisolone acetate eye drops in tapering doses for 4 weeks
Trial: 32610257
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1000 mg/d)
Trial: 35835336
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with mitomycin C (MMC, 0.4 mg/ml for 2 minutes)
Trial: 35544780
Drug: Standard sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard sterile gauze dressing (control group, n = 16), changed after 24 to 48 hours and replaced daily for 5 days.
Trial: 39147573
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment alone
Trial: 34483297
Drug: Combination cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination cognitive behavioral therapy and medication management algorithm (COMB‐R)
Trial: 34348189
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy technique (CT)
Trial: 32133164
Drug: IYCF +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IYCF + WASH (20g small-quantity lipid-based nutrient supplement/day from 6 to 18 months, complementary feeding counselling, pit latrine, 2 hand-washing stations, liquid soap, chlorine, play space, hygiene counselling)
Trial: 32332930
Drug: Genotype-based warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genotype-based warfarin dosing
Trial: 32332930
Drug: Standard warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard warfarin dosing
Trial: 32326325
Drug: P2Y12 inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: P2Y12 inhibitors (Ticagrelor and Clopidogrel)
Trial: 33070009
Drug: Buspirone (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (7.5 mg twice daily, titrated to maximum 30 mg twice daily)
Trial: 35921450
Drug: Cinpanemab 250
RxNorm normalized name: Cinpanemab
DrugBank: Cinpanemab (DB16127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinpanemab 250 mg
Trial: 35921450
Drug: Cinpanemab 1250
RxNorm normalized name: Cinpanemab
DrugBank: Cinpanemab (DB16127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinpanemab 1250 mg
Trial: 35921450
Drug: Cinpanemab 3500
RxNorm normalized name: Cinpanemab
DrugBank: Cinpanemab (DB16127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinpanemab 3500 mg
Trial: 32636281
Drug: Optimised background
RxNorm normalized name: Optimised human arginase I
DrugBank: Pegzilarginase (DB14780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimised background therapy (OBT) plus maraviroc (MVC)
Trial: 32636281
Drug: Optimised background
RxNorm normalized name: Optimised human arginase I
DrugBank: Pegzilarginase (DB14780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimised background therapy (OBT) alone
Trial: 33785651
Drug: Venetoclax tablets
DrugBank: Venetoclax (DB11581)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Venetoclax tablets
Trial: 32614368
Drug: Lidocaine (L‐SLNB)
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine (L‐SLNB)
Trial: 33998885
Drug: Cannabidivarin (CBDV)
RxNorm normalized name: Cannabidivarin
DrugBank: Cannabidivarin (DB14050)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabidivarin (CBDV) 800 mg twice daily (b.i.d.)
Trial: 32356586
Drug: Oral methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral methotrexate (MTX) plus narrowband ultraviolet light B (NB‐UVB) phototherapy, 10 mg oral MTX weekly and NB‐UVB sessions twice weekly for 12 weeks
Trial: 32356586
Drug: Oral methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral methotrexate (MTX) monotherapy, 10 mg oral MTX weekly
Trial: 37384482
Drug: Concurrent Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure
Trial: 35842004
Drug: AZD5718 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5718 200 mg
Trial: 35842004
Drug: AZD5718 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5718 50 mg
Trial: 36284992
Drug: rosuvastatin, amlodipine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin, amlodipine, Ziyin Huoxue Recipe, and aspirin (experimental group)
Trial: 33188208
Drug: Artificial nectar
RxNorm normalized name: Nectarine
DrugBank: Nectarine (DB10656)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial nectar with added nicotine and anabasine (treatment)
Trial: 32429733
Drug: Evervac vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evervac vaccine
Trial: 32429733
Drug: TBE-Moscow vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBE-Moscow vaccine
Trial: 33454782
Drug: European cooperation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: European cooperation packages with greater scope of medicines regulated
Trial: 35476651
Drug: Nasal high-flow
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high-flow therapy
Trial: 33992292
Drug: Music-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music-based physical therapy
Trial: 35063953
Drug: As-needed low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: As-needed low-dose combination budesonide-formoterol
Trial: 35063953
Drug: Maintenance inhaled
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance inhaled corticosteroids (ICS)
Trial: 33389797
Drug: Lorcaserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin (10 mg BID)
Trial: 35627855
Drug: Robotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic therapy (30 min)
Trial: 35627855
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (30 min)
Trial: 35093240
Drug: SY-004 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY-004 (2 mg)
Trial: 35093240
Drug: SY-004 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY-004 (20 mg)
Trial: 35093240
Drug: SY-004 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY-004 (40 mg)
Trial: 35093240
Drug: SY-004 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY-004 (80 mg)
Trial: 35093240
Drug: SY-004 (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY-004 (120 mg)
Trial: 35093240
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 mg, 40 mg, 80 mg, 120 mg)
Trial: 35093240
Drug: SY-004 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY-004 (all doses)
Trial: 36109026
Drug: Telephone-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based cognitive behavioural therapy
Trial: 35575067
Drug: WP1066 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WP1066 at 8 mg/kg
Trial: 35575067
Drug: WP1066 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WP1066 at 1 mg/kg
Trial: 33554636
Drug: Darolutamide and
RxNorm normalized name: darolutamide
DrugBank: Darolutamide (DB12941)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Darolutamide and hormone therapy
Trial: 33554636
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and hormone therapy
Trial: 34393206
Drug: No medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medications
Trial: 35227973
Drug: Group 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1: Orientation messages recorded in a non-family member's voice (10 min), reading a daily newspaper, wearing an eye patch at night
Trial: 35227973
Drug: Group 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2: Orientation messages recorded in a family member's voice, reading a daily newspaper, wearing an eye patch at night
Trial: 35051209
Drug: PC-6500 (0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-6500 (0.1% GRFT in a carrageenan gel)
Trial: 32918114
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment with FVIII/FIX
Trial: 32918114
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment with FVIII/FIX in SHB
Trial: 32918114
Drug: On-demand therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand therapy and hepatitis B and C
Trial: 32787925
Drug: Self-administered therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered therapy (SAT)
Trial: 33665997
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA) 15 mg/kg intravenous drops before operation incision at 10 min
Trial: 33665997
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (100 ml normal saline intravenous drops before operation incision at 10 min)
Trial: 36267873
Drug: Sertraline for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline for 14 weeks
Trial: 34516036
Drug: Learning Through
RxNorm normalized name: Noxzema Clean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Learning Through Play (LTP) plus Culturally adapted Cognitive Behaviour Therapy (CaCBT)
Trial: 36442217
Drug: Premature infant
RxNorm normalized name: Premature infant formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premature infant oral motor intervention for five minutes twice a day along with routine care (n=16)
Trial: 37855069
Drug: Deferasirox dispersible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferasirox dispersible tablets (DT)
Trial: 34431240
Drug: Vonoprazan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vonoprazan (20 mg) after overnight fast
Trial: 34431240
Drug: Vonoprazan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vonoprazan (20 mg) after high-fat breakfast
Trial: 36328438
Drug: Quadrivalent inactivated
RxNorm normalized name: Fluarix Quadrivalent 2018-2019
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent inactivated influenza vaccine
Trial: 35460410
Drug: Pharmacist-led intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-led intervention using validated tools to detect signs and symptoms of medicine-induced deterioration every 8 weeks over 12 months
Trial: 35460410
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (Residential Medication Management Review) provided by accredited pharmacists
Trial: 32039559
Drug: Low-dose CNI
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CNI plus costimulation blockade (belatacept) with intended CNI withdrawal
Trial: 33499719
Drug: Parent Attitudes
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent Attitudes about Childhood Vaccines (PACV) survey
Trial: 36496124
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia (Control)
Trial: 33159633
Drug: Sequential tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential tamoxifen → letrozole
Trial: 33159633
Drug: Sequential letrozole
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential letrozole → tamoxifen
Trial: 34193518
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care (immobilisation, analgesics, spinal orthoses)
Trial: 33515378
Drug: Acetic acid
RxNorm normalized name: Acetic acid
DrugBank: Acetic acid (DB03166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetic acid (AA) solution (0.005%) irrigated by a water pump
Trial: 33295220
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous ketamine infusion (0.5 mg/kg bolus at induction, 0.25 mg/kg/h during surgery)
Trial: 33295220
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous ketamine infusion
Trial: 34774810
Drug: Waitlist Treatment-as-usual
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waitlist Treatment-as-usual
Trial: 33180098
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 injection (1000 μg of cyanocobalamin)
Trial: 33180098
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 injection
Trial: 33180098
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 injection and Placebo
Trial: 35670659
Drug: Daily titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily titration of iGlarLixi (1 unit/day)
Trial: 35670659
Drug: Weekly titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly titration of iGlarLixi (2 or 4 units/week)
Trial: 33749539
Drug: CHO mouth
RxNorm normalized name: moth bean extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO mouth rinse (6.4% maltodextrin = 1.6 g)
Trial: 33749539
Drug: CAF mouth
RxNorm normalized name: moth bean extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAF mouth rinse (1.2% caffeine = 300 mg)
Trial: 33860732
Drug: New Zealand
RxNorm normalized name: NEW ZEALAND GREEN MUSSEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Zealand blackcurrant (NZBC) powder (6 g/day for 7 days, with 138.6 mg anthocyanins)
Trial: 32838616
Drug: OD-evening 80
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: OD-evening 80 mg aspirin
Trial: 32838616
Drug: BID 40
RxNorm normalized name: Lorabid 400mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BID 40 mg aspirin
Trial: 32838616
Drug: OD-morning 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OD-morning 80 mg aspirin